Editas Medicine, Inc. (NASDAQ:EDIT) Receives $15.00 Consensus PT from Analysts
Editas Medicine, Inc. (NASDAQ:EDIT – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the nine brokerages that are covering the firm, MarketBeat.com reports. Four research analysts have rated the stock with a hold rating and five have issued a buy rating on the company. The average 12 month price target […]
More Stories
Meta Platforms (NASDAQ:META) Shares Down 0.8% – Time to Sell?
Meta Platforms, Inc. (NASDAQ:META – Get Free Report) was down 0.8% during mid-day trading on Friday . The company traded...
NeuroSense Therapeutics Ltd. (NASDAQ:NRSN) Short Interest Update
NeuroSense Therapeutics Ltd. (NASDAQ:NRSN – Get Free Report) saw a large decrease in short interest in the month of November....
Short Interest in Direxion Daily AMZN Bull 2X Shares (NASDAQ:AMZU) Drops By 32.9%
Direxion Daily AMZN Bull 2X Shares (NASDAQ:AMZU – Get Free Report) saw a large decrease in short interest during the...
SoFi Technologies (NASDAQ:SOFI) Trading Up 4.1% – Should You Buy?
SoFi Technologies, Inc. (NASDAQ:SOFI – Get Free Report) shot up 4.1% on Friday . The company traded as high as...
Home Depot (NYSE:HD) Trading Up 0.3% – Time to Buy?
The Home Depot, Inc. (NYSE:HD – Get Free Report) shares traded up 0.3% during trading on Friday . The company...
Micron Technology (NASDAQ:MU) Stock Price Down 0.7% – Here’s What Happened
Micron Technology, Inc. (NASDAQ:MU – Get Free Report) shares dropped 0.7% on Friday . The stock traded as low as...